Home Conferences Contact Us Continuing Education Jobs Weekly News Archives Readership Profile

Monthly News Archives Pharmacy Awards Search Site Search Magazine Archives



9 August 2002 News Update


A four-fold increase on drug therapy for mild to moderate Alzheimer's disease resulted in a one-third decline in total costs, according to a study published in the March issue of Managed Care Interface.

The study looked at claims for 408 patients in a Medicare managed care plan, 204 of who were taking the drug and a control group of another 204 randomly selected untreated patients.

The average prescription drugs were US$352 for the control group compare to US $1,398 for the group receiving drug therapy. However, the patients receiving drug therapy had inpatient hospital costs of US$2,883 less than the control group.

Back to welcome page

Back to news archives


Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here
For the answers to last month's quiz click here.


Click here to find out who the winners are for the Pharmacy Today/Zuellig Pharma Pharmacy Awards 2002. Also view and purchase photos of the Awards.


For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.


To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.

Consumer Health Information

New Zealand Doctor Online